Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect

Psychoneuroendocrinology

Volumn 36, Issue 9, 2011, Pages 1312-1326

  Dabrowska, Joanna ^a   Hazra, Rimi ^a   Ahern, Todd H ^b   Guo, Ji Dong ^a   McDonald, Alexander J ^c   Mascagni, Franco ^c   Muller, Jay F ^c   Young, Larry J ^a   Rainnie, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

BNST; CRF; CRF receptor 2; Hypothalamus; Oxytocin; Oxytocin receptor; Paraventricular nucleus; Supraoptic nucleus

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GLUTAMATE DECARBOXYLASE 67; OXYTOCIN; OXYTOCIN RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 2;

AFFECT; ANIMAL TISSUE; ARTICLE; BED NUCLEUS OF THE STRIA TERMINALIS; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HYPOTHALAMUS; IMMUNOFLUORESCENCE; MALE; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; STRIA TERMINALIS; SUPRAOPTIC NUCLEUS; WESTERN BLOTTING;

AFFECT; ANIMALS; ARGININE VASOPRESSIN; COLCHICINE; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK, PHYSIOLOGICAL; HOMEOSTASIS; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROANATOMY; NEURONS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL;

EID: 80052711690     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.03.003     Document Type: Article

References (83)

1. Alheid G.F. Extended amygdala and basal forebrain. Ann. N.Y. Acad. Sci. 2003, 985:185-205.
2. Amico J.A., Cai H.M., Vollmer R.R. Corticosterone release in oxytocin gene deletion mice following exposure to psychogenic versus non-psychogenic stress. Neurosci. Lett. 2008, 442:262-266.
3. Amico J.A., Mantella R.C., Vollmer R.R., Li X. Anxiety and stress responses in female oxytocin deficient mice. J. Neuroendocrinol. 2004, 16:319-324.
4. Arima H., Aguilera G. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors. J. Neuroendocrinol. 2000, 12:833-842.
5. Arluison M., Vankova M., Cesselin F., Leviel V. Origin of some enkephalin-containing afferents to the ventro-medial region of the globus pallidus in the rat. Brain Res. Bull. 1990, 25:25-34.
6. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 2000, 24:410-414.
7. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J. Neurosci. 2001, 21:2546-2552.
8. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
9. Caldwell H.K., Lee H.J., Macbeth A.H., Young W.S. Vasopressin: behavioral roles of an " original" neuropeptide. Prog. Neurobiol. 2008, 84:1-24.
10. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 1995, 15:6340-6350.
11. Chen A.M., Perrin M.H., Digruccio M.R., Vaughan J.M., Brar B.K., Arias C.M., Lewis K.A., Rivier J.E., Sawchenko P.E., Vale W.W. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2620-2625.
12. Chen Y., Brunson K.L., Muller M.B., Cariaga W., Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 2000, 420:305-323.
13. Choi D.C., Furay A.R., Evanson N.K., Ostrander M.M., Ulrich-Lai Y.M., Herman J.P. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J. Neurosci. 2007, 27:2025-2034.
14. Cooper M.A., Huhman K.L. Corticotropin-releasing factor type II (CRF-sub-2) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in Syrian hamsters (Mesocricetus auratus). Behav. Neurosci. 2005, 119:1042-1051.
15. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., Murray S.E., Hill J.K., Pantely G.A., Hohimer A.R., Hatton D.C., Phillips T.J., Finn D.A., Low M.J., Rittenberg M.B., Stenzel P., Stenzel-Poore M.P. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:403-409.
16. Dabrowska J., Rainnie D.G. Expression and distribution of Kv4 potassium channel subunits and potassium channel interacting proteins in subpopulations of interneurons in the basolateral amygdala. Neuroscience 2010, 171:721-733.
17. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol. Psychiatry 1998, 44:1239-1247.
18. De Vries G.J., Buijs R.M. The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res. 1983, 273:307-317.
19. Dong H.W., Petrovich G.D., Watts A.G., Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J. Comp. Neurol. 2001, 436:430-455.
20. Ebner K., Bosch O.J., Kromer S.A., Singewald N., Neumann I.D. Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology 2005, 30:223-230.
21. Griebel G., Simiand J., Serradeil-Le Gal C., Wagnon J., Pascal M., Scatton B., Maffrand J.P., Soubrie P. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6370-6375.
22. Hammack S.E., Mania I., Rainnie D.G. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J. Neurophysiol. 2007, 98:638-656.
23. Hancock M.B. Two-color immunoperoxidase staining: visualization of anatomic relationships between immunoreactive neural elements. Am. J. Anat. 1986, 175:343-352.
24. Hauger R.L., Risbrough V., Oakley R.H., Olivares-Reyes J.A., Dautzenberg F.M. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N.Y. Acad. Sci. 2009, 1179:120-143.
25. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7:605-611.
26. Hu J., Ludwig T.E., Salli U., Stormshak F., Mirando M.A. Autocrine/paracrine action of oxytocin in pig endometrium. Biol. Reprod. 2001, 64:1682-1688.
27. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248.
28. Insel T.R., Hulihan T.J. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav. Neurosci. 1995, 109:782-789.
29. Iremonger K.J., Benediktsson A.M., Bains J.S. Glutamatergic synaptic transmission in neuroendocrine cells: basic principles and mechanisms of plasticity. Front. Neuroendocrinol. 2010, 31:296-306.
30. Ji G., Neugebauer V. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J. Neurophysiol. 2007, 97:3893-3904.
31. Kageyama K., Suda T. Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocr. J. 2009, 56:335-344.
32. Kawasaki A., Shutoh F., Nogami H., Hisano S. VGLUT2 expression is up-regulated in neurohypophysial vasopressin neurons of the rat after osmotic stimulation. Neurosci. Res. 2006, 56:124-127.
33. Kells A.P., Henry R.A., Connor B. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Ther. 2008, 15:966-977.
34. Kells A.P., Henry R.A., Hughes S.M., Connor B. Verification of functional AAV-mediated neurotrophic and anti-apoptotic factor expression. J. Neurosci. Methods 2007, 161:291-300.
35. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 1999, 848:141-152.
36. Labuschagne I., Phan K.L., Wood A., Angstadt M., Chua P., Heinrichs M., Stout J.C., Nathan P.J. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413.
37. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
38. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7570-7575.
39. Lim M.M., Nair H.P., Young L.J. Species and sex differences in brain distribution of corticotropin-releasing factor receptor subtypes 1 and 2 in monogamous and promiscuous vole species. J. Comp. Neurol. 2005, 487:75-92.
40. Lim M.M., Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm. Behav. 2006, 50:506-517.
41. Liu H.L., Cao R., Jin L., Chen L.W. Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res. 2002, 948:175-179.
42. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:836-840.
43. Mantella R.C., Vollmer R.R., Amico J.A. Corticosterone release is heightened in food or water deprived oxytocin deficient male mice. Brain Res. 2005, 1058:56-61.
44. Markakis E.A., Palmer T.D., Randolph-Moore L., Rakic P., Gage F.H. Novel neuronal phenotypes from neural progenitor cells. J. Neurosci. 2004, 24:2886-2897.
45. Markovic D., Punn A., Lehnert H., Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 2008, 22:689-706.
46. Martin E.I., Ressler K.J., Jasnow A.M., Dabrowska J., Hazra R., Rainnie D.G., Nemeroff C.B., Owens M.J. A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol. Psychiatry 2010, 67:1212-1216.
47. McCarthy M.M., McDonald C.H., Brooks P.J., Goldman D. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol. Behav. 1996, 60:1209-1215.
48. Miyata I., Shiota C., Chaki S., Okuyama S., Inagami T. Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2alpha (CRF(2)alpha-tr) in the rat brain. Biochem. Biophys. Res. Commun. 2001, 280:553-557.
49. Miyata I., Shiota C., Ikeda Y., Oshida Y., Chaki S., Okuyama S., Inagami T. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala. Biochem. Biophys. Res. Commun. 1999, 256:692-696.
50. Moore F.L., Richardson C., Lowry C.A. Sexual dimorphism in numbers of vasotocin-immunoreactive neurons in brain areas associated with reproductive behaviors in the roughskin newt. Gen. Comp. Endocrinol. 2000, 117:281-298.
51. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., Kormann M.S., Droste S.K., Kuhn R., Reul J.M., Holsboer F., Wurst W. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 2003, 6:1100-1107.
52. Neumann I.D., Wigger A., Torner L., Holsboer F., Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J. Neuroendocrinol. 2000, 12:235-243.
53. Nguyen N.K., Keck M.E., Hetzenauer A., Thoeringer C.K., Wurst W., Deussing J.M., Holsboer F., Muller M.B., Singewald N. Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology (Berl.) 2006, 188:374-385.
54. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego, CA.
55. Peters A., Palay S.L., Webster H.deF. The Fine Structure of the Nervous System 1991, Oxford University Press, New York.
56. Petersson M., Lundeberg T., Uvnas-Moberg K. Oxytocin enhances the effects of clonidine on blood pressure and locomotor activity in rats. J. Auton. Nerv. Syst. 1999, 78:49-56.
57. Radulovic J., Sydow S., Spiess J. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J. Neurosci. Res. 1998, 54:507-521.
58. Ring R.H., Malberg J.E., Potestio L., Ping J., Boikess S., Luo B., Schechter L.E., Rizzo S., Rahman Z., Rosenzweig-Lipson S. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl.) 2006, 185:218-225.
59. Ross H.E., Cole C.D., Smith Y., Neumann I.D., Landgraf R., Murphy A.Z., Young L.J. Characterization of the oxytocin system regulating affiliative behavior in female prairie voles. Neuroscience 2009, 162:892-903.
60. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., Olive M.F. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl.) 2006, 186:122-132.
61. Saphier D., Feldman S. Electrophysiology of limbic forebrain and paraventricular nucleus connections. Brain Res. Bull. 1986, 17:743-750.
62. Shekhar A., Truitt W., Rainnie D., Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 2005, 8:209-219.
63. Shepherd G.M. The dendritic spine: a multifunctional integrative unit. J. Neurophysiol. 1996, 75:2197-2210.
64. Simerly R.B., Swanson L.W. Castration reversibly alters levels of cholecystokinin immunoreactivity within cells of three interconnected sexually dimorphic forebrain nuclei in the rat. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:2087-2091.
65. Sofroniew M.V. Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog. Brain Res. 1983, 60:101-114.
66. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004, 128:7-14.
67. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
68. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 2002, 943:142-150.
69. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 2003, 980:206-212.
70. van den Pol A.N. The magnocellular and parvocellular paraventricular nucleus of rat: intrinsic organization. J. Comp. Neurol. 1982, 206:317-345.
71. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
72. Veinante P., Freund-Mercier M.J. Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J. Comp. Neurol. 1997, 383:305-325.
73. Viviani D., Stoop R. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog. Brain Res. 2008, 170:207-218.
74. Waldherr M., Neumann I.D. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16681-16684.
75. Walker D.L., Toufexis D.J., Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 2003, 463:199-216.
76. Walter A., Mai J.K., Lanta L., Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J. Chem. Neuroanat. 1991, 4:281-298.
77. Waselus M., Nazzaro C., Valentino R.J., Van Bockstaele E.J. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol. Psychiatry 2009, 66:76-83.
78. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
79. Wittmann G., Fuzesi T., Liposits Z., Lechan R.M., Fekete C. Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain. J. Comp. Neurol. 2009, 517:825-840.
80. Yoshimura R., Kiyama H., Kimura T., Araki T., Maeno H., Tanizawa O., Tohyama M. Localization of oxytocin receptor messenger ribonucleic acid in the rat brain. Endocrinology 1993, 133:1239-1246.
81. Young L.J., Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004, 7:1048-1054.
82. Zhang Z., Bhalla A., Dean C., Chapman E.R., Jackson M.B. Synaptotagmin IV: a multifunctional regulator of peptidergic nerve terminals. Nat. Neurosci. 2009, 12:163-171.
83. Zhao Y., Valdez G.R., Fekete E.M., Rivier J.E., Vale W.W., Rice K.C., Weiss F., Zorrilla E.P. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. J. Pharmacol. Exp. Ther. 2007, 323:846-854.